
Isaac Shomer
Examiner (ID: 12146, Phone: (571)270-7671 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612 |
| Total Applications | 1343 |
| Issued Applications | 756 |
| Pending Applications | 157 |
| Abandoned Applications | 491 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18647671
[patent_doc_number] => 20230293441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => SUGAR-COATED MELANIN NANOPARTICLES AND METHOD FOR TARGETING METASTATIC CANCER CELLS
[patent_app_type] => utility
[patent_app_number] => 18/122221
[patent_app_country] => US
[patent_app_date] => 2023-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18122221
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/122221 | SUGAR-COATED MELANIN NANOPARTICLES AND METHOD FOR TARGETING METASTATIC CANCER CELLS | Mar 15, 2023 | Pending |
Array
(
[id] => 19075262
[patent_doc_number] => 11944604
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-04-02
[patent_title] => Nanoformulation of spriooxindole and methods for treating hepatocellular carcinoma
[patent_app_type] => utility
[patent_app_number] => 18/120298
[patent_app_country] => US
[patent_app_date] => 2023-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 20
[patent_no_of_words] => 8333
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18120298
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/120298 | Nanoformulation of spriooxindole and methods for treating hepatocellular carcinoma | Mar 9, 2023 | Issued |
Array
(
[id] => 20163768
[patent_doc_number] => 20250255814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-14
[patent_title] => LIPOSOMAL DRUG CARRIER BOUND TO THE BLOOD CELL MEMBRANES, AND PREPARATION METHODS THEREFOR, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/847717
[patent_app_country] => US
[patent_app_date] => 2023-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18847717
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/847717 | LIPOSOMAL DRUG CARRIER BOUND TO THE BLOOD CELL MEMBRANES, AND PREPARATION METHODS THEREFOR, AND USES THEREOF | Mar 9, 2023 | Pending |
Array
(
[id] => 18483577
[patent_doc_number] => 20230210875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => LIPOSOMAL COMPOSITION FOR USE IN A METHOD OF TREATING PARKINSON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/181163
[patent_app_country] => US
[patent_app_date] => 2023-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18181163
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/181163 | LIPOSOMAL COMPOSITION FOR USE IN A METHOD OF TREATING PARKINSON'S DISEASE | Mar 8, 2023 | Pending |
Array
(
[id] => 18610953
[patent_doc_number] => 20230277683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => Methods of Making and Using Nanoparticles for Treatment of Bacterial Biofilm
[patent_app_type] => utility
[patent_app_number] => 18/175610
[patent_app_country] => US
[patent_app_date] => 2023-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15080
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175610
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/175610 | Methods of Making and Using Nanoparticles for Treatment of Bacterial Biofilm | Feb 27, 2023 | Pending |
Array
(
[id] => 18901251
[patent_doc_number] => 20240016736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA
[patent_app_type] => utility
[patent_app_number] => 18/114434
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17703
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18114434
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/114434 | PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA | Feb 26, 2023 | Abandoned |
Array
(
[id] => 18877576
[patent_doc_number] => 20240000945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => CO-AMORPHOUS FORM OF A SUBSTANCE AND A PROTEIN
[patent_app_type] => utility
[patent_app_number] => 18/166339
[patent_app_country] => US
[patent_app_date] => 2023-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11173
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18166339
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/166339 | CO-AMORPHOUS FORM OF A SUBSTANCE AND A PROTEIN | Feb 7, 2023 | Pending |
Array
(
[id] => 18565562
[patent_doc_number] => 20230255889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => SUSTAINED RELEASE PARTICLE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/107353
[patent_app_country] => US
[patent_app_date] => 2023-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18107353
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/107353 | Sustained release particle formulations | Feb 7, 2023 | Issued |
Array
(
[id] => 18418410
[patent_doc_number] => 20230172868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => LIPID-BASED NANOPARTICLES WITH ENHANCED STABILITY
[patent_app_type] => utility
[patent_app_number] => 18/104620
[patent_app_country] => US
[patent_app_date] => 2023-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18104620
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/104620 | LIPID-BASED NANOPARTICLES WITH ENHANCED STABILITY | Jan 31, 2023 | Abandoned |
Array
(
[id] => 20254871
[patent_doc_number] => 12427204
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-30
[patent_title] => Antibody-bound lipid nanoparticle comprising antibody bound to membrane scaffold protein
[patent_app_type] => utility
[patent_app_number] => 18/833679
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 2251
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18833679
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/833679 | Antibody-bound lipid nanoparticle comprising antibody bound to membrane scaffold protein | Jan 26, 2023 | Issued |
Array
(
[id] => 18535904
[patent_doc_number] => 20230240990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => LIPOSOMES ENCAPSULATING ADENOSINE
[patent_app_type] => utility
[patent_app_number] => 18/159675
[patent_app_country] => US
[patent_app_date] => 2023-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9432
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159675
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/159675 | LIPOSOMES ENCAPSULATING ADENOSINE | Jan 24, 2023 | Pending |
Array
(
[id] => 18389715
[patent_doc_number] => 20230157933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => Semisolid Oral Dispersions Comprising Active Agents
[patent_app_type] => utility
[patent_app_number] => 18/100201
[patent_app_country] => US
[patent_app_date] => 2023-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18100201
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/100201 | Semisolid oral dispersions comprising active agents | Jan 22, 2023 | Issued |
Array
(
[id] => 18737806
[patent_doc_number] => 20230346702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => LIPID NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/150528
[patent_app_country] => US
[patent_app_date] => 2023-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 639
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150528
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/150528 | LIPID NANOPARTICLES | Jan 4, 2023 | Pending |
Array
(
[id] => 18364923
[patent_doc_number] => 20230146514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => ORAL COMPOSITIONS AND THE PREPARATION METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/150399
[patent_app_country] => US
[patent_app_date] => 2023-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6326
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150399
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/150399 | Oral compositions and the preparation methods thereof | Jan 4, 2023 | Issued |
Array
(
[id] => 18334059
[patent_doc_number] => 20230126007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => NANOPARTICLES ENCAPSULATING SOLUBLE BIOLOGICS, THERAPEUTICS, AND IMAGING AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/083458
[patent_app_country] => US
[patent_app_date] => 2022-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18083458
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/083458 | NANOPARTICLES ENCAPSULATING SOLUBLE BIOLOGICS, THERAPEUTICS, AND IMAGING AGENTS | Dec 15, 2022 | Pending |
Array
(
[id] => 18510116
[patent_doc_number] => 20230226217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => RNA FORMULATION FOR IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 18/071705
[patent_app_country] => US
[patent_app_date] => 2022-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18071705
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/071705 | RNA FORMULATION FOR IMMUNOTHERAPY | Nov 29, 2022 | Pending |
Array
(
[id] => 18297668
[patent_doc_number] => 20230107354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => In Vivo Targeting of Extracellular Vesicles
[patent_app_type] => utility
[patent_app_number] => 17/992209
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14967
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17992209
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/992209 | In Vivo Targeting of Extracellular Vesicles | Nov 21, 2022 | Pending |
Array
(
[id] => 18434273
[patent_doc_number] => 20230181567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => Liposomes Useful for Drug Delivery
[patent_app_type] => utility
[patent_app_number] => 17/988857
[patent_app_country] => US
[patent_app_date] => 2022-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41372
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17988857
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/988857 | Liposomes Useful for Drug Delivery | Nov 16, 2022 | Abandoned |
Array
(
[id] => 19096276
[patent_doc_number] => 20240115503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => INTRAVESICAL DELIVERY OF HYDROPHILIC THERAPEUTIC AGENTS USING LIPOSOMES
[patent_app_type] => utility
[patent_app_number] => 18/011635
[patent_app_country] => US
[patent_app_date] => 2022-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011635
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011635 | INTRAVESICAL DELIVERY OF HYDROPHILIC THERAPEUTIC AGENTS USING LIPOSOMES | Nov 10, 2022 | Pending |
Array
(
[id] => 18610726
[patent_doc_number] => 20230277456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => LEVERAGING LIPID-PROTEIN INTERACTIONS TO ENGINEER SPATIAL ORGANIZATION IN CELL-FREE SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 18/054131
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18054131
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/054131 | LEVERAGING LIPID-PROTEIN INTERACTIONS TO ENGINEER SPATIAL ORGANIZATION IN CELL-FREE SYSTEMS | Nov 8, 2022 | Pending |